A review of 20 studies on depression screening conducted by researchers at Cedars-Sinai Medical Center in Los Angeles found 33 percent of hospital patients involved in the studies displayed symptoms of depression. Previous research has shown depressed patients are less likely to appropriately adhere to medication recommendations and carry an increased risk of readmission.
“Upon admission to the hospital, patients are screened for all kinds of medical issues such as abnormalities in blood pressure, cholesterol and blood sugar,” said lead study author Waguih William IsHak, MD, associate professor of psychiatry and behavioral neurosciences at Cedars-Sinai Medical Center, according to a report from HealthDay. “Adding a screening for depression seizes a golden opportunity to initiate and maintain treatment … These findings show that hospitals might experience improved outcomes by initiating a depression screening program.”
More articles on quality:
AHA urges CMS: Use only quality measures that matter
61% of pediatric nurses in poor work environments miss care, study shows
Researchers assess surgical skill by measuring clinician sweat
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
